JPS57203064A - Amide derivative, manufacture and pharmaceutical composition containing same and having gastric acid secretion control activity - Google Patents

Amide derivative, manufacture and pharmaceutical composition containing same and having gastric acid secretion control activity

Info

Publication number
JPS57203064A
JPS57203064A JP57036000A JP3600082A JPS57203064A JP S57203064 A JPS57203064 A JP S57203064A JP 57036000 A JP57036000 A JP 57036000A JP 3600082 A JP3600082 A JP 3600082A JP S57203064 A JPS57203064 A JP S57203064A
Authority
JP
Japan
Prior art keywords
manufacture
pharmaceutical composition
composition containing
gastric acid
amide derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57036000A
Other languages
English (en)
Other versions
JPH0261456B2 (ja
Inventor
Oregon Ierin Tobiasu
Jiyon Giruman Debuitsuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Zeneca Inc
Original Assignee
Imperial Chemical Industries Ltd
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd, ICI Americas Inc filed Critical Imperial Chemical Industries Ltd
Publication of JPS57203064A publication Critical patent/JPS57203064A/ja
Publication of JPH0261456B2 publication Critical patent/JPH0261456B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
JP57036000A 1981-03-09 1982-03-09 Amide derivative, manufacture and pharmaceutical composition containing same and having gastric acid secretion control activity Granted JPS57203064A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8107272 1981-03-09

Publications (2)

Publication Number Publication Date
JPS57203064A true JPS57203064A (en) 1982-12-13
JPH0261456B2 JPH0261456B2 (ja) 1990-12-20

Family

ID=10520234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57036000A Granted JPS57203064A (en) 1981-03-09 1982-03-09 Amide derivative, manufacture and pharmaceutical composition containing same and having gastric acid secretion control activity

Country Status (5)

Country Link
US (2) US4496564A (ja)
EP (1) EP0060093B1 (ja)
JP (1) JPS57203064A (ja)
CA (1) CA1209998A (ja)
DE (1) DE3271313D1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008201496A (ja) * 2007-02-16 2008-09-04 Tohoku Rubber Kk ハンドレールの接続構造及びその製造方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059597B1 (en) * 1981-02-27 1986-04-23 Imperial Chemical Industries Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
US4452985A (en) * 1983-02-14 1984-06-05 American Home Products Corporation 2-Guanyl-4-(substituted phenyl) thiazole derivatives
US6590502B1 (en) * 1992-10-12 2003-07-08 911Ep, Inc. Led warning signal light and movable support
KR100863336B1 (ko) 2006-09-29 2008-10-15 한국화학연구원 신규 옥사졸-4-카르보닐구아니딘 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 허혈성 심장질환의 예방 및 치료용 약학적 조성물
EA201100073A1 (ru) * 2008-06-23 2011-10-31 Интеллиджент Тауер Солюшнс Апс Платформа, в частности внутренняя платформа для трубчатой башни
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021448A (en) * 1975-10-21 1977-05-03 Sterling Drug Inc. 2-Substituted-indole-1-lower-alkanecarboxamides
US4117131A (en) * 1976-12-07 1978-09-26 Warner-Lambert Company Method of inhibiting gastric acid secretions with 2-(4-pyrimidinyl)thioacetamides
US4248784A (en) * 1977-02-25 1981-02-03 Sterling Drug Inc. Pyrrole-3-acetamides
NO781300L (no) * 1977-04-20 1978-10-23 Ici Ltd Fremgangsmaate for fremstilling av fysiologisk aktive guanidinderivater
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
US4315009A (en) * 1978-01-18 1982-02-09 Imperial Chemical Industries Limited Antisecretory guanidine derivatives and pharmaceutical compositions containing them
ATE1353T1 (de) * 1978-05-24 1982-08-15 Imperial Chemical Industries Plc Anti-sekretion thiadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
JPS5536447A (en) * 1978-09-07 1980-03-14 Otsuka Pharmaceut Co Ltd Butyramide derivative
US4309435A (en) * 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
DE3069889D1 (en) * 1979-01-18 1985-02-14 Ici Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
JPS55118468A (en) * 1979-03-02 1980-09-11 Morishita Seiyaku Kk Thioamide derivative
JPS55118469A (en) * 1979-03-02 1980-09-11 Morishita Seiyaku Kk Thioamide derivative
PH16099A (en) * 1979-03-06 1983-06-24 Yamanouchi Pharma Co Ltd Guanidinothiazole compounds,process for preparing them and medical composition containing them
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them
JPS5646873A (en) * 1979-09-26 1981-04-28 Yamanouchi Pharmaceut Co Ltd 2-guanidinothiazole derivative and its preparation
JPS56108777A (en) * 1980-02-01 1981-08-28 Yamanouchi Pharmaceut Co Ltd Novel guanidinothiazole derivative and its preparation
JPS56122368A (en) * 1980-02-29 1981-09-25 Yamanouchi Pharmaceut Co Ltd Guanidinothiazole compound and its preparation
US4402975A (en) * 1980-07-21 1983-09-06 Teijin Limited Aminocarboxylic acids, amino alcohols, or the derivatives thereof, processes for production thereof, and pharmaceutical uses thereof
EP0059597B1 (en) * 1981-02-27 1986-04-23 Imperial Chemical Industries Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
US4460584A (en) * 1981-03-13 1984-07-17 Imperial Chemical Industries Plc Nitrogen heterocycles
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008201496A (ja) * 2007-02-16 2008-09-04 Tohoku Rubber Kk ハンドレールの接続構造及びその製造方法

Also Published As

Publication number Publication date
CA1209998A (en) 1986-08-19
DE3271313D1 (en) 1986-07-03
EP0060093A3 (en) 1982-11-17
EP0060093B1 (en) 1986-05-28
JPH0261456B2 (ja) 1990-12-20
US4696933A (en) 1987-09-29
US4496564A (en) 1985-01-29
EP0060093A2 (en) 1982-09-15

Similar Documents

Publication Publication Date Title
IL74882A0 (en) Naphthyridine-,quinoline-and benzoxazine-carboxylic acids and derivatives thereof,their manufacture and pharmaceutical compositions containing them
JPS5753449A (en) 2-hydroxy-5-phenylazobenzoic acid derivative, manufacture and medicinal composition
IL66056A0 (en) Alkanoic acid derivatives,their production and pharmaceutical composition containing them
IL65056A0 (en) Imidazodiazepines,their manufacture and pharmaceutical compositions containing them
IL75586A0 (en) Pharmaceutical compositions containing indole-2-alkanoic acids and derivatives thereof,and certain such novel compounds
IL64847A0 (en) Hexapyranose compounds,their manufacture and pharmaceutical compositions containing them
JPS5798281A (en) Azabicyclooctane-carboxylic acid, manufacture and pharmaceutical composition containing same
JPS6463575A (en) Thiomethyl and sulfinylmethyl derivative having gastric acid secretion control, manufacture and pharmaceutical composition
JPS57159781A (en) Dihydrobenzofuranyl derivative, manufacture and medicinal composition containing same
IL64732A0 (en) Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS57183772A (en) Aminocyclopentanol acids and esters, manufacture and medicinal composition
JPS57183736A (en) Novel derivative of phenylaliphatic carboxylic acid, manufacture, use as drug and composition containing same
JPS57203064A (en) Amide derivative, manufacture and pharmaceutical composition containing same and having gastric acid secretion control activity
JPS57206664A (en) Guanidine derivative, manufacture and histamine h-2-antagonistic and gastric acid secretion inhibiting pharmaceutical composition containing same
DE3265871D1 (en) 3-amino-2-hydroxy-4-phenylbutanoic acid derivatives and pharmaceutical composition containing the same
HK86292A (en) Dihydroorotic acid derivatives,processes for their prepararing and pharmaceutical composition containing them
JPS57165373A (en) Guanidine derivative, manufacture and medicinal composition containing same for gastric acid secretion inhibition
IL77105A (en) N-(dialkylaminoethyl)-cyanobenzamide derivatives,process for their manufacture and pharmaceutical compositions containing them
JPS57167969A (en) Guanidine derivative, manufacture and pharmaceutical composition containing same and having gastric acid secretion control
JPS57171980A (en) Guanidine derivative, manufacture and gastric acid secretion inhibitor containing same
IL76897A (en) Crystalline 2-penem-3-carboxylic acid derivative,its manufacture and pharmaceutical compositions containing it
GB8414123D0 (en) Pharmaceutical pellet
JPS57181066A (en) Trichomonas-exterminating nitroimidazoles, manufacture and pharmaceutical composition
IL62326A0 (en) 7 beta-amido-3-cephem-4-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL70513A (en) N-methyl-carbamic acid ester derivatives,their production and their use for controlling pests